Tricida, Inc.·4

Mar 2, 4:52 PM ET

Otto Dawn Parsell 4

4 · Tricida, Inc. · Filed Mar 2, 2022

Insider Transaction Report

Form 4
Period: 2022-02-28
Otto Dawn Parsell
Sr VP, Clinical Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-02-28+256,000256,000 total
    Exercise: $7.96Exp: 2032-02-27Common Stock (256,000 underlying)
Footnotes (1)
  • [F1]The option to purchase common stock will vest as follows: (a) 25% of the shares subject to the options shall vest on February 28, 2023, and (b) the remaining 75% vest in 36 equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date.

Documents

1 file
  • 4
    wf-form4_164625788702871.xmlPrimary

    FORM 4